Physician profile
Lisa Young
NPI 1861694911
$8,783.81
in general payments reported to CMS, 2019-2025
38 companies · $1,347 in 2025
The $1,347 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,582 · 2020: $621 · 2021: $1,428 · 2022: $1,524 · 2023: $1,308 · 2024: $974 · 2025: $1,347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,580 · Education: $49.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,580.00 |
| Education | $49.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,645.01 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $1,609.72 | 2019-2024 | |
| Lilly USA, LLC | $904.71 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $522.85 | 2019-2025 | Evenity, Prolia, Tepezza |
| Mannkind Corporation | $479.29 | 2019-2024 | Afrezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $462.58 | 2019-2025 | Jardiance, Synjardy |
| Tandem Diabetes Care, INC. | $358.05 | 2020-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Astrazeneca Pharmaceuticals LP | $325.31 | 2019-2023 | Breztri |
| Xeris Pharmaceuticals, INC. | $277.92 | 2021-2025 | Gvoke Hypopen |
| Medtronic, INC. | $265.43 | 2021-2025 | Minimed 780g |
| Insulet Corporation | $170.89 | 2021-2025 | Omnipod |
| Abbvie INC. | $170.11 | 2019-2025 | Synthroid |
| Novartis Pharmaceuticals Corporation | $167.45 | 2024-2025 | |
| Ibsa Pharma INC. | $149.36 | 2021-2024 | Tirosint, Licart, Tirosint |
| Abbott Laboratories | $123.67 | 2019-2024 | Freestyle Libre 3 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $120.00 | 2023 | Arexvy |
| Merck Sharp & Dohme LLC | $119.04 | 2019-2022 | |
| Amarin Pharma, INC. | $111.68 | 2019-2021 | |
| Dexcom, INC. | $111.31 | 2019-2025 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $93.72 | 2020-2025 | Korlym |
| Chiesi USA, INC. | $89.69 | 2025 | Mycapssa |
| Medtronic Minimed, INC. | $81.74 | 2019-2020 | |
| Beta Bionics, INC. | $79.63 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Bayer Healthcare Pharmaceuticals INC. | $55.80 | 2023-2024 | |
| Madrigal Pharmaceuticals | $46.12 | 2025 | Rezdiffra |
| Clarus Therapeutics INC. | $38.05 | 2021 | |
| Radius Health, INC. | $29.13 | 2020-2024 | |
| Sequel Med Tech, LLC | $22.15 | 2025 | Twiist |
| Grt US Holding, INC. | $21.97 | 2022 | |
| Acerus Pharmaceuticals Corporation | $18.22 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.01 | 2021 | |
| Acella Pharmaceuticals, LLC | $16.64 | 2025 | NP Thyroid 60 |
| Cequr Corporation | $14.35 | 2021 | |
| Ascendis Pharma Endocrinology INC | $14.26 | 2023 | |
| Amneal Pharmaceuticals LLC | $13.97 | 2025 | Unithroid |
| Kvk-Tech, INC. | $12.64 | 2019 | |
| Lifescan, INC. | $11.88 | 2021 | |
| Alexion Pharmaceuticals, INC. | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.